Prof. Dr. Carolin Daniel
Head Research Unit Type 1 Diabetes Immunology (TDI) & Professor Immune Modulation Division of Clinical Pharmacology Ludwig-Maximilians-Universität (LMU)"The core of my research is the immunology of diabetes. The focus here is on so-called regulatory T lymphocytes (Treg cells), which in the healthy immune system enable the vital distinction between endogenous and exogenous and thus maintain so-called immune tolerance."
"The core of my research is the immunology of diabetes. The focus here is on so-called regulatory T lymphocytes (Treg cells), which in the healthy immune system enable the vital distinction between endogenous and exogenous and thus maintain so-called immune tolerance."
Academic Career and Research Areas
Carolin Daniel's scientific career focused early on diabetology, with a particular focus on the immunology of diabetes. She conducted her PhD within the DFG Research Training Group at the University of Frankfurt and at the Karolinska Institute in Stockholm. With a Leopoldina fellowship she completed her postdoc on "Immune tolerance of type 1 diabetes" in the field of diabetology/immunology in the laboratory of Prof. Harald von Boehmer (Harvard Medical School, Boston/USA).
Within the framework of a Leopoldina returnee fellowship, she returned to Germany in March 2012 and established her own research group on "Immunology of Type 1 Diabetes" with a focus on immune tolerance at the Helmholtz Diabetes Center Munich (Institute of Diabetes Research, Director Professor Anette-G. Ziegler) by means of a Helmholtz junior research group. The junior research group at the Helmholtz Diabetes Center was successfully evaluated internationally at the end of 2016 and consolidated as a research unit. In June 2019, Carolin Daniel accepted the professorship of Immunomodulation (Clinical Pharmacology/Immunopharmacology) as part of the joint appointment by LMU and Helmholtz Zentrum München. Since October 2022, she has headed the independent Research Unit "Type 1 Diabetes Immunology" (TDI).
In addition, Carolin Daniel is involved in various functions in numerous initiatives and networks, including:
- Head of the Type 1 Diabetes Academy of the German Center for Diabetes Research (DZD)
- Spokesperson of the Cross-Center Activity "Immunology and Inflammation" at Helmholtz Zentrum München
- Spokesperson of the International Helmholtz Research School for Diabetes
- Coordinator of the Helmholtz Munich Immunology Cross-Topic Activity
- Board member of the SFB1054 of the German Research Foundation (DFG) "Control and Plasticity of Cell-Fate Decisions in the Immune System" at LMU Munich
- Co-organizer of the Helmholtz Diabetes Center Seminar Series
- Member of the appointment committee for new institutes at Helmholtz Zentrum München
Fields of Work and Expertise
Immune SystemImmune ToleranceImmune ModulationAutoimmunityType 1 DiabetesRegulatory T cellsAntigen-Specific Regulatory T CellsTissue-Specific Regulatory T CellsmicroRNAS
Professional Background
Head of the Research Unit "Type 1 Diabetes Immunology" (TDI).
Professor of Immunomodulation (W2) at the Ludwig-Maximilians-University (LMU) Munich, LMU Munich Hospital, Department of Clinical Pharmacology.
Head of the research group "Immune Tolerance in Diabetes" at the Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg, Germany.
Independent Junior Research Group Leader (Junior Research Group "Immune Tolerance in Type 1 Diabetes") at the Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg, Germany.
Research Fellow in Microbiology and Immunobiology at Harvard Medical School (Prof. Dr. Harald von Boehmer), Boston, USA.
Post-Doc at Dana Farber Cancer Institute/Department of Cancer Immunology and Aids, Boston, USA (Prof. Dr. Harald von Boehmer).
Post-Doc at the Johann Wolfgang Goethe-University Frankfurt, Institute of Pharmacology/Immunopharmacology (Prof. Dr. Josef Pfeilschifter)
Honors and Awards
2021 Isil Berat Barlan Award for Outstanding Women Scientists in Immunology
2021 Member of AcademiaNet nominated by the Helmholtz Association of German Research Centers
2021 Ferdinand Bertram Award of the German Diabetes Society (DDG)
2021 Research Prize 2021 of the Heinz-Bürger-Büsing Foundation for research in diabetes.
2020 Early Career Research Prize in Vaccinology R&D from the International Union of Im-munology Societies (IUIS) and Vaccines Europe.
2019 Nils-Ilja Richter Prize of the German Society for Autoimmune Diseases (DGfAE).
2018 Georges Köhler Prize of the German Society for Immunology (DGfI)
2017 Awarded as "New leader in the field" by the Women in Metabolism/Rosie Project of the journal Cell Metabolism.
2017 Selection as a scientist for the research area Health in the magazine of the Helmholtz Society for the journal ZEIT "Where the future begins"
2017 Ernst Friedrich Pfeiffer Prize of the German Diabetes Society (DDG)
2016 Elected as "Rising Star" to present at the Helmholtz Horizons opening symposium in Berlin.
2014 Nomination for the HelDi Award as "Rising Star" at the 2nd Helmholtz-Nature Medicine Diabetes Conference Munich.
2010 Prize for the best poster presentation, Annual Meeting of the Department for Cancer Im-munology and AIDS, Boston, USA
2008 Fritz-Külz-Prize 2007, German Society for Experimental and Clinical Pharmacology and Toxicology
2007 Science Award of the Rhine-Main Society for Gastroenterology
Highlight Publications
See all
Networks and Affiliations
